Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device

Inclusion Criteria

• •For COPD patients:
• •Patients able and willing to sign an informed consent to participate in the study;
• •Patient is aged 40 years or older with a smoking history of ≥10 pack years;
• •Patients with COPD confirmed previously by a detailed medical history and examination;
• •Patients presenting with moderate or severe exacerbation of chronic obstructive pulmonary disease.
• •Patient is treated by a monotherapy long-acting muscarinic antagonist (LAMA), or LAMA plus long acting beta2-agonist (LABA), or inhaled corticosteroid (ICS) plus LABA, or LAMA plus LABA plus ICS.
• •For asthma patients:
• •Patients able and willing to sign an informed consent to participate in the study;
• •Patient is aged 3 years or older;
• •Patients with asthma confirmed previously by a detailed medical history and examination;
• •Patients presenting with moderate or severe exacerbation of asthma;
• •Patient is treated by a monotherapy ICS or ICS plus LABA or other controllers.